Afficher la couverture 'Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study | Jensen, Poul Erik H.' en grand format
/5

0 avis

Consulter en ligne

Suggestions

Du même auteur

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Archive ouverte | Hässler, Signe | CCSD

International audience. Background: Biopharmaceutical products (BPs) are widely used to treat autoimmune diseases, but immunogenicity limits their efficacy for an important proportion of patients. Our knowledge of p...

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Archive ouverte | Link, Jenny | CCSD

International audience. Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a wellintegrated part of the clinical care of multiple sclerosis (MS) in several European countries. ADA data gener...

Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients

Archive ouverte | Adriani, Marsilio | CCSD

International audience. , and Genentech; he has served as DMSC member for AllergyCare; he or his institution have received speaker honoraria from Biogen Idec, Teva Neuroscience, Merck Serono, Medimmune, Novartis, De...

Chargement des enrichissements...